IMRAIMARA Inc.

NAS · US · Healthcare · Biotechnology
14.59USD0.00%Mkt Cap: P/E:

The manager seeks to achieve these investment objectives through the use of a synthetic covered call strategy. The manager seeks to provide its synthetic exposure to the price return of MARA through the purchase and sale…

Key Statistics

Company
Market Cap
Enterprise Value
Revenue (TTM)
Gross Profit
Net Income (TTM)
Revenue/Share
Last Price14.59 USD
Fiscal Year End
MR Quarter
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B
EPS (TTM)
EPS (Forward)
52W Range
11.999% of range42.32
52W High42.32 USD
52W Low11.99 USD
Profitability
Gross Margin
Oper. Margin
EBITDA Margin
Profit Margin
ROE
ROA
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio
Quick Ratio
Book Value/Sh
Cash/Share
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield37.89%
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float
Insiders
Institutions
Technical
SMA 5015.94 (-8.5%)
SMA 20016.48 (-11.5%)
Beta
S&P 52W Chg
Avg Vol (30d)2.15K
Avg Vol (10d)1.56K
Technical Indicators
RSI (14)37.4
MACD-0.4024
MACD Signal-0.4830
MACD Hist.+0.0806
BB Upper15.58 USD
BB Middle14.69 USD
BB Lower13.80 USD
BB Width12.08%
ATR (14)0.2039 USD
Vol Ratio (20d)0.00x